Oral Administration of Tissue-Targeted TLR7 Agonists for Immune Oncology
Time: 4:30 pm
day: Day One
Details:
- Unpicking the mechanistic studies of our tissue-targeted approaches,
- Exploring the preclinical models
- Assessing cytokine responses as it pertains to tissue distribution and residence time
